Brought to you by

Abbott gets license to MacroArray's PSA test
15 Mar 2007
Executive Summary
MacroArray Technologies (diagnostic markers for cancer) licensed Abbott rights to develop and market its PCADM-1 test for prostate cancer.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com